Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study
出版年份 2019 全文链接
标题
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study
作者
关键词
-
出版物
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-20
DOI
10.1111/jdv.16159
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients
- (2019) Vasiliki Nikolaou et al. SUPPORTIVE CARE IN CANCER
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events
- (2019) Heike C. Hawerkamp et al. ALLERGY
- Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients
- (2018) Gregory S. Phillips et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institutional, retrospective analysis with stratification of reactions by toxicity and implications for management
- (2018) Emily Coleman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Outpatient dermatology consultation impacts the diagnosis and management of pediatric oncology patients: A retrospective study
- (2017) Hannah Song et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings
- (2017) V. Sibaud et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
- (2016) Vincent Sibaud et al. CURRENT OPINION IN ONCOLOGY
- Association of Dermatology Consultation With Accuracy of Cutaneous Disorder Diagnoses in Hospitalized Patients
- (2016) Daniela Kroshinsky et al. JAMA Dermatology
- Xerosis and pruritus as major EGFRI-associated adverse events
- (2015) Julia M. K. Clabbers et al. SUPPORTIVE CARE IN CANCER
- Experience of a year of adult hospital dermatology consultations
- (2014) Eoin R. Storan et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Impact of Dermatology Consultation on Diagnostic Accuracy and Antibiotic Use Among Patients With Suspected Cellulitis Seen at Outpatient Internal Medicine Offices
- (2014) Ryan Y. Arakaki et al. JAMA Dermatology
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic
- (2013) Alyx C. Rosen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Life-threatening dermatologic adverse events in oncology
- (2013) Alyx C. Rosen et al. ANTI-CANCER DRUGS
- Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group
- (2013) Rebecca K. S. Wong et al. SUPPORTIVE CARE IN CANCER
- Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterization
- (2012) Aaron M. Drucker et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
- (2012) Alice P. Chen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study
- (2012) Emily Y. Chu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib
- (2011) IRIS AMITAY-LAISH et al. Dermatologic Therapy
- The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies
- (2011) Yevgeniy Balagula et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
- (2011) C. B. Boers-Doets et al. ONCOLOGIST
- Pediatric Dermatology Consultations: A Retrospective Analysis of Inpatient Consultations Referred to the Dermatology Service
- (2011) YERAY PEÑATE et al. PEDIATRIC DERMATOLOGY
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
- (2011) Mario E. Lacouture et al. SUPPORTIVE CARE IN CANCER
- Dermatology inpatient consultations: A retrospective study
- (2010) Jacob Bauer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of Hand-Foot Skin Reaction with the Multitargeted Kinase Inhibitor Sunitinib in Patients with Renal Cell and Non–Renal Cell Carcinoma: A Meta-analysis
- (2009) David Chu et al. Clinical Genitourinary Cancer
- Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
- (2008) S. E. Rosenbaum et al. SUPPORTIVE CARE IN CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started